Human Metapneumovirus: A New Player among Respiratory Viruses

Boivin, Guy; Hamelin, Marie-Ève; Abed, Yacine
April 2004
Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p983
Academic Journal
The human metapneumovirus (hMPV) is a newly described member of the Paramyxoviridae family belonging to the Me-tapneumovirus genus. Since its initial description in 2001, hemp has been reported in most parts of the world and isolated from the respiratory tract of subjects from all age groups. Despite the fact that prospective and case-control studies have been limited, the epidemiologist and clinical manifestations associated with hemp have been found to be reminiscent of those of the human respiratory syncytial virus, with most severe respiratory tract infections occurring in infants, elderly subjects, and immunocompromised hosts. Additional research is needed to define the pathogenesis of this viral infection and the host's specific immune response.


Related Articles

  • The pathogenesis of respiratory syncytial virus disease in childhood. McNamara, Paul S.; Smyth, Rosalind L. // British Medical Bulletin;Mar2002, Vol. 61 Issue 1, p13 

    Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infection in infants and children. RSV is an RNA virus whose genome encodes 10 proteins. The G protein is responsible for viral attachment to cells whilst the F protein promotes syncytia formation. These proteins are also...

  • Age-Related Differences in Pulmonary Cytokine Response to Respiratory Syncytial Virus Infection: Modulation by Anti-inflammatory and Antiviral Treatment. Boukhvalova, Marina S.; Yim, Kevin C.; Kuhn, Katie H.; Hemming, John P.; Prince, Gregory A.; Porter, David D.; Blanco, Jorge C. G. // Journal of Infectious Diseases;2/15/2007, Vol. 195 Issue 4, p511 

    Background. Respiratory syncytial virus (RSV) is the major cause of severe lower respiratory tract infection in infants and young children. Recently, RSV has also been recognized as a serious health risk in elderly individuals, but the pathogenesis of RSV infection in elderly individuals remains...

  • Respiratory Syncytial Virus: Current Progress in Vaccine Development. Rudraraju, Rajeev; Jones, Bart G.; Sealy, Robert; Surman, Sherri L.; Hurwitz, Julia L. // Viruses (1999-4915);Feb2013, Vol. 5 Issue 2, p577 

    Respiratory syncytial virus (RSV) is the etiological agent for a serious lower respiratory tract disease responsible for close to 200,000 annual deaths worldwide. The first infection is generally most severe, while re-infections usually associate with a milder disease. This observation and the...

  • Diagnostic utility of BINAX NOW RSV -- an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence. Jonathan, Nteimam // Annals of Clinical Microbiology & Antimicrobials;2006, Vol. 5, p13 

    Background: The regular increase in the incidence of respiratory illness caused by respiratory syncytial virus (RSV) during winter months in the United Kingdom, and other countries with temperate climate is usually accompanied by increased bed pressures especially in paediatric units in these...

  • Respiratory Syncytial Virus and Parainfluenza Virus. Hall, Caroline Breese // New England Journal of Medicine;06/21/2001, Vol. 344 Issue 25, p1917 

    Focuses on respiratory syncytial virus (RSV) and parainfluenza virus. Classification and structure; Epidemiologic features; Pathogenesis; Effect of disease in children and adults; Reinfections in previously healthy persons; Immunity; Diagnosis; Prospects for immunization; Prophylaxis with immune...

  • The Need for Validation of Statistical Methods for Estimating Respiratory Virus–Attributable Hospitalization. Gilca, Rodica; De Serres, Gaston; Skowronski, Danuta; Boivin, Guy; Buckeridge, David L. // American Journal of Epidemiology;Oct2009, Vol. 170 Issue 7, p925 

    Public policy regarding influenza has been based largely on the burden of hospitalization estimated through ecologic studies applying increasingly sophisticated statistical methods to administrative databases. None are known to have been validated by observational studies. The authors...

  • Burden of Respiratory Syncytial Viral Infections on Paediatric Hospitals: A Two-Year Prospective Epidemiological Study. Constantopoulos, A. G.; Kafetzis, D. A.; Syrogiannopoulos, G. A.; Roilides, E. J.; Malaka-Zafiriu, E. E.; Sbyrakis, S. S.; Marcopoulos, M. L. // European Journal of Clinical Microbiology & Infectious Diseases;Feb2002, Vol. 21 Issue 2, p102 

    This study was designed to prospectively investigate the hospitalisation patterns for respiratory syncytial virus (RSV) disease in children up to 2 years of age, both healthy full-term children and high-risk children. The aim was to evaluate children hospitalised for a respiratory tract...

  • RSV bigger cause of bronchitis than flu.  // Pulse;5/7/2005, Vol. 65 Issue 18, p16 

    This article cites a study of children in Great Britain, which states that respiratory syncytial virus (RSV) is a more important cause of respiratory infections than infiuenza in children under the age of four. Researchers found RSV was twice as likely as flu to cause acute bronchitis and was...

  • Viral etiologies of lower respiratory tract infections among Egyptian children under five years of age. Shafik, Caroline F.; Mohareb, Emad W.; Yassin, Aymen S.; Amin, Madgy A.; El Kholy, Amani; El-Karaksy, Hanaa; Youssef, Fouad G. // BMC Infectious Diseases;2012, Vol. 12 Issue 1, p350 

    Background: Lower respiratory tract infections (LRTI) are responsible for a considerable number of deaths among children, particularly in developing countries. In Egypt and the Middle East region, there is a lack of data regarding the viral causes of LRTI. In this study, we aimed to identify the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics